A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Summary

The aim of this study is to test the effect of the combination of valproate in combination with imatinib with an aim of achieving a maximal molecular response as the primary goal.

Timeline

Start

2009-09

Primary completion

2010-06

Completion

2010-07

Outcome

Outcome not reported

Stopped (Enrollment): “Withdrawn due to lack of accrual per Center DSMP, with PI concurrence”

Drugs

Indications